J. Amess

3.3k total citations
68 papers, 2.4k citations indexed

About

J. Amess is a scholar working on Hematology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, J. Amess has authored 68 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 19 papers in Pathology and Forensic Medicine and 17 papers in Genetics. Recurrent topics in J. Amess's work include Acute Myeloid Leukemia Research (23 papers), Lymphoma Diagnosis and Treatment (18 papers) and Acute Lymphoblastic Leukemia research (14 papers). J. Amess is often cited by papers focused on Acute Myeloid Leukemia Research (23 papers), Lymphoma Diagnosis and Treatment (18 papers) and Acute Lymphoblastic Leukemia research (14 papers). J. Amess collaborates with scholars based in United Kingdom, United States and Italy. J. Amess's co-authors include D. L. Mollin, Tim Lister, A. J. Norton, J. Matthews, A. Z. S. Rohatiner, Jeremy Whelan, Gareth Rees, D. G. Nancekievill, Peter Johnson and C. G. A. Price and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

J. Amess

66 papers receiving 2.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
J. Amess 922 706 663 540 349 68 2.4k
M. E. J. Beard 321 0.3× 725 1.0× 383 0.6× 468 0.9× 460 1.3× 72 2.1k
Thomas Elter 1.1k 1.2× 397 0.6× 820 1.2× 1.1k 2.1× 130 0.4× 68 2.4k
Margaret P. Sullivan 439 0.5× 301 0.4× 433 0.7× 311 0.6× 624 1.8× 75 2.0k
S Richards 177 0.2× 1.0k 1.5× 352 0.5× 434 0.8× 1.2k 3.4× 40 3.5k
Harshal Nandurkar 288 0.3× 558 0.8× 463 0.7× 359 0.7× 286 0.8× 118 3.6k
Caroline Elie 193 0.2× 619 0.9× 256 0.4× 430 0.8× 214 0.6× 101 3.4k
Alexandros A. Drosos 808 0.9× 584 0.8× 286 0.4× 179 0.3× 202 0.6× 127 4.2k
A. Weel 569 0.6× 372 0.5× 622 0.9× 164 0.3× 220 0.6× 93 4.0k
Mauro Montanari 275 0.3× 681 1.0× 660 1.0× 304 0.6× 520 1.5× 75 2.3k
Roberta Priori 420 0.5× 562 0.8× 314 0.5× 128 0.2× 233 0.7× 158 3.9k

Countries citing papers authored by J. Amess

Since Specialization
Citations

This map shows the geographic impact of J. Amess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Amess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Amess more than expected).

Fields of papers citing papers by J. Amess

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Amess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Amess. The network helps show where J. Amess may publish in the future.

Co-authorship network of co-authors of J. Amess

This figure shows the co-authorship network connecting the top 25 collaborators of J. Amess. A scholar is included among the top collaborators of J. Amess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Amess. J. Amess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Provan, Drew, et al.. (2005). Myelodysplastic syndrome associated with trisomy 2. Clinical & Laboratory Haematology. 27(4). 270–273.
2.
Ngan, Samuel Y., A. Z. S. Rohatiner, J. Matthews, et al.. (2003). Waldenstrom's macroglobulinemia: A retrospective analysis of 40 patients from 1972 to 2001. Seminars in Oncology. 30(2). 236–238. 3 indexed citations
3.
Foran, James M., John Apostolidis, D. Papamichael, et al.. (1998). High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: A study of 27 patients from a single centre. Annals of Oncology. 9(8). 865–869. 67 indexed citations
4.
Papamichael, D., et al.. (1996). Intensive chemotherapy for adult acute lymphoblastic leukaemia given with or without granulocyte-macrophage colony stimulating factor. Annals of Hematology. 73(6). 259–263. 8 indexed citations
5.
MacCallum, Peter K., A. Z. S. Rohatiner, Catherine L. Davis, et al.. (1995). Mitoxantrone and cytosine arabinoside as treatment for acute myeloblastic leukemia in older patients. Annals of Hematology. 71(1). 35–39. 15 indexed citations
6.
Malpas, J. S., Peter Johnson, Peter Clark, et al.. (1995). Myeloma during a decade: Clinical experience in a single centre. Annals of Oncology. 6(1). 11–18. 4 indexed citations
7.
Johnson, Peter, A. Z. S. Rohatiner, Jeremy Whelan, et al.. (1995). Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center.. Journal of Clinical Oncology. 13(1). 140–147. 265 indexed citations
8.
White, Peter D., Shibani Grover, H. O. Kangro, et al.. (1995). The validity and reliability of the fatigue syndrome that follows glandular fever. Psychological Medicine. 25(5). 917–924. 49 indexed citations
9.
Bower, Mark, et al.. (1994). Human trithorax gene rearrangements in therapy-related acute leukaemia after etoposide treatment.. PubMed. 8(2). 226–9. 18 indexed citations
10.
Karmiris, Efthymios, A. Z. S. Rohatiner, Sharon Love, et al.. (1994). The management of chronic lymphocytic leukemia at a single centre over a 24‐year period: prognostic factors for survival. Hematological Oncology. 12(1). 29–39. 15 indexed citations
11.
Davis, Catherine L., A. Z. S. Rohatiner, J. Lim, et al.. (1993). The management of recurrent acute myelogenous leukaemia at a single centre over a fifteen‐year period. British Journal of Haematology. 83(3). 404–411. 32 indexed citations
12.
Oza, Amit M., Martin J. Leahy, E. Dorey, et al.. (1991). Recombinant human granulocyte macrophage colony stimulating factor following alternating non cross resistant chemotherapy in hodgkin's disease. Hematological Oncology. 9(6). 337–347. 4 indexed citations
13.
Davis, Catherine L., A. Z. S. Rohatiner, J. Amess, & T. Andrew Lister. (1991). Oral idarubicin as a palliative agent in leukemia. Hematological Oncology. 9(1). 59–60. 6 indexed citations
14.
Tucker, J., Abin Thomas, Walter M. Gregory, et al.. (1990). Acute myeloid leukemia in elderly adults. Hematological Oncology. 8(1). 13–21. 32 indexed citations
15.
Bassan, Renato, R Battista, MJ Barnett, et al.. (1990). High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia. British Journal of Cancer. 62(3). 454–458. 36 indexed citations
16.
Davis, Catherine L., A. Z. S. Rohatiner, J. Amess, J. Lim, & Tim Lister. (1990). Treatment of Recurrent Acute Myelogenous Leukaemia at a Single Centre Over a 10-Year Period. Hämatologie und Bluttransfusion. 33. 339–341. 1 indexed citations
17.
Richards, Martin, Peter A. Hall, Walter M. Gregory, et al.. (1989). Lymphoplasmacytoid and small cell centrocytic non‐Hodgkin's lymphoma—A retrospective analysis from St Bartholomew's hospital 1972–1986. Hematological Oncology. 7(1). 19–35. 20 indexed citations
18.
Amos, R., et al.. (1988). Autosomal inheritance of sideroblastic anaemia. Clinical & Laboratory Haematology. 10(3). 347–354. 8 indexed citations
19.
Bassan, Renato, A. Z. S. Rohatiner, Walter M. Gregory, et al.. (1987). The Treatment of Acute Myelogenous Leukemia. Hämatologie und Bluttransfusion. 31. 35–36. 9 indexed citations
20.
Amess, J., J. F. Burman, M. F. Murphy, A. M. Paxton, & D. L. Mollin. (1981). Severe megaloblastic bone marrow change associated with unsuspected mild vitamin B12deficiency. Clinical & Laboratory Haematology. 3(3). 231–237. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. E. J. Beard Breakdown of academic impact, for papers by Thomas Elter Breakdown of academic impact, for papers by Margaret P. Sullivan Breakdown of academic impact, for papers by S Richards Breakdown of academic impact, for papers by Harshal Nandurkar Breakdown of academic impact, for papers by Caroline Elie Breakdown of academic impact, for papers by Alexandros A. Drosos Breakdown of academic impact, for papers by A. Weel Breakdown of academic impact, for papers by Mauro Montanari Breakdown of academic impact, for papers by Roberta Priori
Rankless by CCL
2026